Status:
COMPLETED
Development of Artificial Intelligence Models for Segmentation and Characterization of Prostate Cancer: a Single-center Retrospective Observational Study.
Lead Sponsor:
IRCCS San Raffaele
Conditions:
Prostate Cancer
Eligibility:
MALE
18+ years
Brief Summary
Prostate cancer is the second most common cancer in the male population. This pathology represents an oncological and public health problem especially in developed countries, due to a greater presence...
Eligibility Criteria
Inclusion
- Patients with histological diagnosis of prostate cancer;
- Patients who performed a PET exam with 68 Ga-PMSA.
Exclusion
- CT and MR images with artifacts that preclude interpretation of results.
Key Trial Info
Start Date :
January 6 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 1 2022
Estimated Enrollment :
350 Patients enrolled
Trial Details
Trial ID
NCT06168864
Start Date
January 6 2020
End Date
June 1 2022
Last Update
December 13 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Irccs San Raffaele
Milan, Italy, 20132